2020台灣生技月 Bio Taiwan 生物科技大展

2020 台灣生技月 南港展覽館

講師

Quark Biosciences, Inc.

Company Presentations

Friday, July 24 Company Presentations 5–Diagnostics, Device, NPO

Quark Biosciences, Inc.

Company Info

Name /Quark Biosciences, Inc.

Address /6-2 Shengyi Rd., Sec. 2, 4F-1 Zhubei, Hsinchu, Taiwan 30261

Website /www.quarkbiosciences.com

Presenter

Name /Eric P. Yang

Title /Vice President

Email /ericyang@quarkbiosciences.com

Telephone /(Work) 03-6590898 #600

Fax /03-6590797

Mobile /

Company Type

Diagnostics

About the Company

Quark Biosciences is a molecular diagnostics company developing first-in-class assays

in precision medicine using proprietary NextAmpTM Analysis System. The analyses of

massive amounts of available genomic data have identified nucleic acid biomarkers

associated with specific pathological conditions, diseases prognosis or treatment

response. We take important bits of genomics information, evaluate their significance, and create novel diagnostic solutions to resolve unmet needs in the

field of precision oncology and reproductive medicine.

Brief Description of main products or services

What is NextAmpTM Analysis System?

NextAmpTM Analysis System is a multi-gene analysis platform with dual functionality, capable of both expression profiling with PenelChip® and digital level quantitation with DigiChip™. Targeted primers are pre-loaded on PanelChip®, providing ready-to-use, easy-to-operate clinical assays with a two-hour turnaround time. Designed using optoelectronic semiconductor technology, PanelChip® makes expression profiling simple, fast, yet concise. Utilizing the high-density gene chip, DigiChip™ with QuarkBio’s proprietary dqPCR platform, the absolute quantification and real-time quantitative analysis can be performed in the same reaction, thus increasing both sensitivity and accuracy for analyzing clinical samples with low quantity.


Application Assays in Oncology and Reproduction Medicine

Alongside our partners in the healthcare, biotechnology, and pharma sectors, QuarkBio has been rapidly developing clinical assays on NextAmpTM Analysis System. Our pipeline includes assays for prediction of immunotherapy responses based on tumor microenvironment; treatment selection for patients with breast cancer after surgery; high sensitivity liquid biopsy for monitoring of lung cancer patients; identifying endometrium receptivity to increase IVF success rate. These assays have been developed in partnership with renowned hospitals and medical centers. 


Contact Person

Name /Yasmin Tseng

Email /yasmintseng@quarkbiosciences.com

Phone /03-6590898 #625